image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Tarsus - Bookings tracking 15% ahead

July 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • TRS
  • Price:
  • 152p
Tarsus' improving momentum has continued with bookings tracking 15% ahead of the same period last year (adjusted for biennial events) as at 14 May. As a result, forward bookings for the year to December now stand at 65% of anticipated full-year revenues compared with 61% at the same time in 2010. In particular, its emerging markets division is going well with recent Turkish acquisition, IFO's, next exhibition, REW Istanbul (international recycling, environmental technologies and waste management) tracking significantly ahead of 2011. Its largest event in Dubai, MEBA (business aviation), is also ahead. Elsewhere, in the US, the medical division is growing strongly, while the Off-Price Show (February  & August) has a ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X